Skip to content

Biogen BIIB Interest Expense

Interest Expense at other companies

Rogers Corporation logo
Rogers CorporationROG
$300K-25.0%
TG Therapeutics logo
TG TherapeuticsTGTX
$7.67M+13.5%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$8.06M+1.9%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$0-100%
Regenxbio logo
RegenxbioRGNX
$8.71M+1.6%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
$0-100%

Other financials

Income statement

See full
Revenue$2.7B+3.4%
Gross profit$2.0B-4.0%
Operating income$610.7M
Net income$97.5M-84.6%
EPS (diluted)$0.66-84.8%

Balance sheet

See full
Cash & equivalents$1.3B-53.4%
Total debt$7.6B+14.6%
Total equity$18.8B+6.9%
Total assets$32.1B+13.3%

Cash flow

See full
Operating cash flow$448.9M+179%
CapEx$40.9M+53.8%
Free cash flow$408.0M+204%

Valuation

See full
Market cap$30.36B+62.0%
Enterprise value$36.63B+62.2%
P/E34.4×+22.1×
P/S+1.2×

Profitability

See full
Gross margin74%-1.4pp
Operating margin22.9%
Net margin8.8%-6.5pp
FCF margin26.9%+7.1pp

Returns & leverage

See full
Return on equity4.8%-4.3pp
Debt / equity0.4×0.0×
Current ratio1.9×-0.6×

Where this comes from

Reported directly by Biogen in its filing.

Tagged under the XBRL concept us-gaap:InterestExpense.

The official record: Biogen’s 10-Q, filed July 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biogen's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biogen's interest expense?
Biogen (BIIB) reported interest expense of $82.3M in Q2 2026.
How has Biogen's interest expense changed year-over-year?
Biogen's interest expense increased by 13.4% year-over-year, from $72.6M to $82.3M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.